Analystreport

Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its price target lowered by analysts at Piper Sandler from $27.00 to $20.00. They now have an "overweight" rating on the

Ocular Therapeutix, Inc.  (OCUL) 
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ocutx.com